These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 25510341)
1. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018). Lam W; Jiang Z; Guan F; Hu R; Liu SH; Chu E; Cheng YC BMC Complement Altern Med; 2014 Dec; 14():490. PubMed ID: 25510341 [TBL] [Abstract][Full Text] [Related]
2. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Lam W; Bussom S; Guan F; Jiang Z; Zhang W; Gullen EA; Liu SH; Cheng YC Sci Transl Med; 2010 Aug; 2(45):45ra59. PubMed ID: 20720216 [TBL] [Abstract][Full Text] [Related]
3. Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment. Wang E; Bussom S; Chen J; Quinn C; Bedognetti D; Lam W; Guan F; Jiang Z; Mark Y; Zhao Y; Stroncek DF; White J; Marincola FM; Cheng YC BMC Med Genomics; 2011 May; 4():38. PubMed ID: 21569348 [TBL] [Abstract][Full Text] [Related]
4. A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer. Kummar S; Copur MS; Rose M; Wadler S; Stephenson J; O'Rourke M; Brenckman W; Tilton R; Liu SH; Jiang Z; Su T; Cheng YC; Chu E Clin Colorectal Cancer; 2011 Jun; 10(2):85-96. PubMed ID: 21859559 [TBL] [Abstract][Full Text] [Related]
5. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Takasuna K; Hagiwara T; Hirohashi M; Kato M; Nomura M; Nagai E; Yokoi T; Kamataki T Cancer Res; 1996 Aug; 56(16):3752-7. PubMed ID: 8706020 [TBL] [Abstract][Full Text] [Related]
6. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531 [TBL] [Abstract][Full Text] [Related]
7. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model. Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870 [TBL] [Abstract][Full Text] [Related]
8. Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats. Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Hagiwara T; Kakihata K; Hirohashi M; Nomura M; Nagai E Jpn J Cancer Res; 1995 Oct; 86(10):978-84. PubMed ID: 7493918 [TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice. Allegrini G; Goulette FA; Darnowski JW; Calabresi P Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007 [TBL] [Abstract][Full Text] [Related]
10. St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis. Hu ZP; Yang XX; Chan SY; Xu AL; Duan W; Zhu YZ; Sheu FS; Boelsterli UA; Chan E; Zhang Q; Wang JC; Ee PL; Koh HL; Huang M; Zhou SF Toxicol Appl Pharmacol; 2006 Oct; 216(2):225-37. PubMed ID: 17015070 [TBL] [Abstract][Full Text] [Related]
11. Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy. Rockwell S; Grove TA; Liu Y; Cheng YC; Higgins SA; Booth CJ Int J Radiat Biol; 2013 Jan; 89(1):16-25. PubMed ID: 22856538 [TBL] [Abstract][Full Text] [Related]
12. A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor. Yang XX; Hu ZP; Xu AL; Duan W; Zhu YZ; Huang M; Sheu FS; Zhang Q; Bian JS; Chan E; Li X; Wang JC; Zhou SF J Pharmacol Exp Ther; 2006 Oct; 319(1):82-104. PubMed ID: 16815871 [TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice. Wu Y; Wang D; Yang X; Fu C; Zou L; Zhang J Biomed Pharmacother; 2019 Jan; 109():2252-2261. PubMed ID: 30551482 [TBL] [Abstract][Full Text] [Related]
15. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002. Shinohara H; Killion JJ; Kuniyasu H; Kumar R; Fidler IJ Clin Cancer Res; 1998 Sep; 4(9):2053-63. PubMed ID: 9748119 [TBL] [Abstract][Full Text] [Related]
16. Are herbal medicines ripe for the cancer clinic? Eng C Sci Transl Med; 2010 Aug; 2(45):45ps41. PubMed ID: 20720215 [TBL] [Abstract][Full Text] [Related]
17. Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea. Ikegami T; Ha L; Arimori K; Latham P; Kobayashi K; Ceryak S; Matsuzaki Y; Bouscarel B Cancer Res; 2002 Jan; 62(1):179-87. PubMed ID: 11782376 [TBL] [Abstract][Full Text] [Related]
18. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. Ikuno N; Soda H; Watanabe M; Oka M J Natl Cancer Inst; 1995 Dec; 87(24):1876-83. PubMed ID: 7494232 [TBL] [Abstract][Full Text] [Related]
19. Single and combined supplementation of glutamine and n-3 polyunsaturated fatty acids on host tolerance and tumour response to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin (CPT-11)/5-fluorouracil chemotherapy in rats bearing Ward colon tumour. Xue H; Le Roy S; Sawyer MB; Field CJ; Dieleman LA; Baracos VE Br J Nutr; 2009 Aug; 102(3):434-42. PubMed ID: 19250573 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy. Xue H; Field CJ; Sawyer MB; Dieleman LA; Baracos VE Br J Cancer; 2009 May; 100(10):1581-8. PubMed ID: 19401694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]